pifithrin has been researched along with Lung Adenocarcinoma in 1 studies
pifithrin: a tetrahydrobenzothiazol; inhibitor of P53 that protects mice from the side effects of cancer therapy; structure in first source
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| An, HK | 1 |
| Kim, KS | 1 |
| Lee, JW | 1 |
| Park, MH | 1 |
| Moon, HI | 1 |
| Park, SJ | 1 |
| Baik, JS | 1 |
| Kim, CH | 1 |
| Lee, YC | 1 |
1 other study available for pifithrin and Lung Adenocarcinoma
| Article | Year |
|---|---|
Mimulone-induced autophagy through p53-mediated AMPK/mTOR pathway increases caspase-mediated apoptotic cell death in A549 human lung cancer cells.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; AMP-Activated Protein Kinases; Antineoplastic Agents, Phytog | 2014 |